QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences
QuidelOrtho (Nasdaq: QDEL) announced that its management team will participate in two June 2026 investor conferences.
Rhea-AI Summary
QuidelOrtho (Nasdaq: QDEL) announced that its management team will participate in two June 2026 investor conferences. The company will present at the William Blair 46th Annual Growth Stock Conference on June 2 at 12:20 p.m. ET and join a fireside chat at the Jefferies Global Healthcare Conference on June 3 at 8:10 a.m. ET. Live webcasts and replays will be available in the “Events & Presentations” section of QuidelOrtho’s Investor Relations website.
Details
News Market Reaction – QDEL
On May 20, the day this news came out, QDEL closed 4.66% above the previous close.
Data tracked by StockTitan Argus for the May 20 session.
Key Figures
- William Blair conference date
- June 2, 2026
- William Blair 46th Annual Growth Stock Conference participation
- Jefferies conference date
- June 3, 2026
- Jefferies Global Healthcare Conference fireside chat
- William Blair presentation time
- 12:20 p.m. ET / 9:20 a.m. PT
- Scheduled presentation slot at William Blair conference
- Jefferies fireside chat time
- 8:10 a.m. ET / 5:10 a.m. PT
- Scheduled fireside chat at Jefferies Global Healthcare Conference
Historical Context
-
Weaker Q1 results and lowered 2026 guidance pressured the stock.
-
Science Bytes episode on U.S. syphilis trends and screening gaps.
-
Announcement that QuidelOrtho would acquire LEX Diagnostics and VELO platform.
-
Completion of roughly $100M LEX Diagnostics acquisition expanding PCR portfolio.
-
Preliminary Q1 revenue miss and lower outlook triggered a sharp sell-off.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
in vitro diagnostics medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
William Blair 46th Annual Growth Stock Conference, Tuesday, June 2, 2026
Members of QuidelOrtho's management team will participate in a presentation at 12:20 p.m. ET / 9:20 a.m. PT.
Jefferies Global Healthcare Conference, Wednesday, June 3, 2026
Members of QuidelOrtho's management team will participate in a fireside chat at 8:10 a.m. ET / 5:10 a.m. PT.
Interested parties can access the live webcast and replay in the "Events & Presentations" section of the "Investor Relations" page of QuidelOrtho's website at https://ir.quidelortho.com/.
QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.
About QuidelOrtho Corporation
With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, dedicated to advancing fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.
Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
IR@QuidelOrtho.com
Media Contact:
Stephanie Kleewein
Senior Corporate Communications and PR Manager
media@QuidelOrtho.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/quidelortho-to-participate-in-upcoming-june-2026-investor-conferences-302777345.html
SOURCE QuidelOrtho Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.